This medicine works by altering the neurotransmitters in the brain that helps in weight loss maintenance.
Side effects
Major & minor side effects for REDUCTIL 15mg Capsule 14s

Back pain

Dizziness

Constipation

Increased heartbeat

Anxiety

Gastritis

Abdominal pain

Migraine

Vomiting

Increased cough

Acne

Urinary retention

Uses of REDUCTIL 15mg Capsule 14s
What is it prescribed for?

Obesity
This medicine helps in reducing the weight of obese patients with body mass index (BMI) ?30 kg/m2 or ? 27 kg/m2 in the presence of risk factors such as diabetes, dyslipidemia, controlled hypertension, etc.

Concerns

Frequently asked questions

Onset of action
The amount of time required for this medicine to show its action is not clinically established.

Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?
Use of this medicine may cause habit-forming tendencies in some cases especially if the usage is for an extended period of time. A gradual withdrawal of the drug i.e. decrease in dosing over a period of time is suggested in such cases.

Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to REDUCTIL 15mg Capsule 14s , or any other inactive ingredients present in the formulation.

Anorexia Nervosa
This medicine is not recommended for use in patients who are suffering from the eating disorder due to the increased risk of worsening of the patient’s condition.

Monoamine oxidase inhibitors (MAOI)
This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of serious and life-threatening side effects. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

Severe Liver/Kidney Impairment
This medicine is not recommended for use in patients with severe liver or kidney diseases due to the increased risk of worsening of the patient’s condition.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

General Warnings

Heart Diseases
This medicine should be used with caution in patients with heart diseases due to the increased risk of a rise in blood pressure and heart rate. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use in Children
This medicine is not recommended for use in patients below 16 years of age since the safety and efficacy of use are not clinically established.

Seizures
This medicine should be used with caution in patients with seizures due to increased risk worsening of the patient’s condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Driving or Operating machinery
Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Dosage

Missed Dose
Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions
Interaction with Medicines

Amitriptyline severe

Ondansetron severe

Tramadol severe

Formoterol moderate

Bupropion severe

Aspirin moderate

Disease interactions

severe
This medicine should be used with caution in patients with narrow-angle glaucoma due to the increased risk of worsening of the patient’s condition. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

severe
This medicine should be used with caution in patients with kidney/liver diseases due to the increased risk of adverse effects. Close monitoring of liver or kidney function tests is necessary while taking this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

moderate
This medicine should be used with caution in patients with diabetes due to the increased risk of hypoglycemia. Regular monitoring of blood glucose levels, dose adjustments of antidiabetic agents, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

General Instructions

Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

References

drugbank –
Sibutramine [Internet].
Available from: https://go.drugbank.com/drugs/DB01105
[cited 11/16/2020].

pubchem. –
Sibutramine [Internet].
Available from: https://pubchem.ncbi.nlm.nih.gov/compound/sibutramine#section=2D-Structure
[cited 11/16/2020].
2020-11-07